The impact of Fogarty International Center research training programs on public health policy and program development in Kenya and Uganda

BMC Public Health

James M M’Imunya¹  Douglas Waswa³  Freddie Ssengooba⁴  Ligia Paina²  Sara Bennett² 

[1] UNITID, University of Nairobi, Nairobi, Kenya;Johns Hopkins School of Public Health, Baltimore, MD, USA;Independent Consultant, Nairobi, Kenya;Makerere University School of Public Health, Kampala, Uganda

关键词: HIV/AIDS;    Policy influence;    Research capacity;   

Others  :  1161910
DOI  :  10.1186/1471-2458-13-770

 received in 2013-02-02, accepted in 2013-08-06,  发布年份 2013

【 摘 要 】

Background

The Fogarty International Center (FIC) has supported research capacity development for over twenty years. While the mission of FIC is supporting and facilitating global health research conducted by U.S. and international investigators, building partnerships between health research institutions in the U.S. and abroad, and training the next generation of scientists to address global health needs, research capacity may impact health policies and programs and therefore have positive impacts on public health. We conducted an exploratory analysis of how FIC research training investments affected public health policy and program development in Kenya and Uganda.

Methods

We explored the long term impacts of all FIC supported research training programs using case studies, in Kenya and Uganda. Semi-structured in-depth interviews were conducted with 53 respondents and 29 focus group discussion participants across the two countries. Qualitative methods were supplemented by structured surveys of trainees and document review, including a review of evidence cited in policy documents.

Results

In the primary focal areas of FIC grants, notably HIV/AIDS, there were numerous examples of work conducted by former FIC trainees that influenced national and global policies. Facilitators for this influence included the strong technical skills and scientific reputations of the trainees, and professional networks spanning research and policy communities. Barriers included the fact that trainees typically had not received training in research communication, relatively few policy makers had received scientific training, and institutional constraints that undermined alignment of research with policy needs.

Conclusions

While FIC has not focused its programs on the goal of policy and program influence, its investments have affected global and national public health policies and practice. These influences have occurred primarily through strengthening research skills of scientists and developing strong in-country networks. Further success of FIC and similar initiatives could be stimulated by investing more in the training of policy-makers, seeking to better align research with policy needs through more grants that are awarded directly to developing country institutions, and grants that better incorporate policy maker perspectives in their design and governance. Addressing structural constraints, for example supporting the development of national research agendas that inform university research, would further support such efforts.

【 授权许可】

   
2013 Bennett et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Whitworth JA, et al.: Strengthening capacity for health research in Africa. Lancet 2008, 372(9649):1590-1593.
• [2]Marjanovic S, et al.: Research capacity building in Africa: networks, institutions and local ownership. J Int Dev 2012. doi:10.1002/jid.2870
• [3]DFID: DFID Research Strategy: 2008–2013. DFID: London; 2008.
• [4]Nchinda TC: Research capacity strengthening in the South. Soc Sci Med 2002, 54(11):1699-1711.
• [5]Gadsby EW: Research capacity strengthening: donor approaches to improving and assessing its impact in low- and middle-income countries. Int J Health Plann Manage 2011, 26(1):89-106.
• [6]Minja H, et al.: Impact of health research capacity strengthening in low- and middle-income countries: the case of WHO/TDR programmes. PLoS Negl Trop Dis 2011, 5(10):e1351. doi:10.1371/journal.pntd.0001351
• [7]Bremen J, et al.: Global health: the Fogarty International Center, National Institutes of Health: vision and Mission, Programs and Accomplishments. Infect Dis Clin North Am 2011, 25(3):311-336. doi:10.1016/j.idc.2011.06.003
• [8]Fauci AS, Folkers GK: Investing to meet the scientific challenges of HIV/AIDS. Health Aff (Millwood) 2009, 28(6):1629-1641.
• [9]Mitton C, et al.: Knowledge transfer and exchange: review and synthesis of the literature. Milbank Q 2007, 85(4):729-768.
• [10]Kok MO, Schuit AJ: Contribution mapping: a method for mapping the contribution of research to enhance its impact. Health Res Policy Syst 2012, 10:21. BioMed Central Full Text
• [11]Wooding S, et al.: Payback arising from research funding: evaluation of the Arthritis Research Campaign. Rheumatology (Oxford) 2005, 44(9):1145-1156.
• [12]Trostle J: Research capacity building in international health: definitions, evaluations and strategies for success. Soc Sci Med 1992, 35(11):1321-1324.
• [13]Gerring J: Case study research: Principles and practice. Cambridge: Cambridge University Press; 2007.
• [14]Musoke P, et al.: A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS 1999, 13(4):479-486.
• [15]Guay LA, et al.: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999, 354(9181):795-802.
• [16]Jackson JB, et al.: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet 2003, 362(9387):859-868.
• [17]Hudson CP, Moodley J: HIVNET nevirapine trials. Lancet 1999, 354(9192):1817-1818.
• [18]Gray RH, et al.: Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007, 369(9562):657-666.
• [19]Adatu F, et al.: Implementation of the DOTS strategy for tuberculosis control in rural Kiboga District, Uganda, offering patients the option of treatment supervision in the community, 1998–1999. Int J Tuberc Lung Dis 2003, 7(9 Suppl 1):S63-S71.
• [20]Mafigiri DK, McGrath JW, Whalen CC: Task shifting for tuberculosis control: a qualitative study of community-based directly observed therapy in urban Uganda. Glob Public Health 2012, 7(3):270-84. doi:10.1080/17441692.2011.552067
• [21]Katamba A, Laticevschi D, Rieder HL: Efficiency of a third serial sputum smear examination in the diagnosis of tuberculosis in Moldova and Uganda. Int J Tuberc Lung Dis 2007, 11(6):659-664.
• [22]Namagembe I, et al.: Consumption of alcoholic beverages among pregnant urban Ugandan women. Matern Child Health J 2010, 14(4):492-500.
• [23]Richardson BA, et al.: Acute HIV infection among Kenyan infants. Clin Infect Dis 2008, 46(2):289-295.
• [24]Rousseau CM, et al.: Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis 2004, 190(10):1880-1888.
• [25]Nduati R, et al.: Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000, 283(9):1167-1174.
• [26]Nduati R, et al.: Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial. Lancet 2001, 357(9269):1651-1655.
• [27]Otieno PA, et al.: HIV-1 disease progression in breast-feeding and formula-feeding mothers: a prospective 2-year comparison of T cell subsets, HIV-1 RNA levels, and mortality. J Infect Dis 2007, 195(2):220-229.
• [28]Kiarie JN, et al.: Infant feeding practices of women in a perinatal HIV-1 prevention study in Nairobi, Kenya. J Acquir Immune Defic Syndr 2004, 35(1):75-81.
• [29]Mbori-Ngacha D, et al.: Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: a randomized clinical trial. JAMA 2001, 286(19):2413-2420.
• [30]Cherutich P, et al.: Optimizing paediatric HIV care in Kenya: challenges in early infant diagnosis. Bull World Health Organ 2008, 86(2):155-160.
• [31]Inwani I, et al.: Performance of clinical algorithms for HIV-1 diagnosis and antiretroviral initiation among HIV-1-exposed children aged less than 18 months in Kenya. J Acquir Immune Defic Syndr 2009, 50(5):492-498.
• [32]Lingappa JR, et al.: Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS One 2009, 4(4):e5272.
• [33]Lingappa JR, et al.: Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. PLoS One 2008, 3(1):e1411.
• [34]Guthrie BL, et al.: Sexually transmitted infections among HIV-1-discordant couples. PLoS One 2009, 4(12):e8276.
• [35]Richardson BA, et al.: Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial. Sex Transm Dis 2001, 28(7):394-400.
• [36]Kaul R, et al.: Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 2004, 291(21):2555-2562.
• [37]Kaul R, et al.: Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis 2007, 196(11):1692-1697.
• [38]Moses S, et al.: Response of a sexually transmitted infection epidemic to a treatment and prevention programme in Nairobi, Kenya. Sex Transm Infect 2002, 78(Suppl 1):i114-i120.
• [39]Voeten HA, et al.: Quality of sexually transmitted disease case management in Nairobi, Kenya: a comparison among different types of healthcare facilities. Sex Transm Dis 2001, 28(11):633-642.
• [40]Haas PM: Epistemic Communities and International-Policy Coordination - Introduction. Int Organ 1992, 46(1):1-35.
• [41]Innvaer S, et al.: Health policy-makers perception of their use of evidence: a systematic review. J Health Serv Res Pol 2002, 7(4):239-244.
• [42]Hyder AA, et al.: National policy-makers speak out: are researchers giving them what they need? Health Policy Plan 2011, 26(1):73-82.
• [43]van Kammen J, de Savigny D, Sewankambo N: Using knowledge brokering to promote evidence-based policy-making: the need for support structures. Bull World Health Organ 2006, 84(8):608-612.
• [44]Kuruvilla S, et al.: Describing the impact of health research: a research impact framework. BMC Health Serv Res 2006, 6:134. BioMed Central Full Text
• [45]Ortiz A, Taylor P: Learning Purposefully in Capacity Development. Why, what and when to measure?. Paris: UNESCO; 2009:1-49.
• [46]Bornmann L: What is the societal impact of resaerch and how can it be assessed? A literature survey. J Am Soc Inf Sci Technol 2013, 64(2):217-233.